PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DGX vs. GILD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DGX and GILD is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

DGX vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quest Diagnostics Incorporated (DGX) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

6,000.00%8,000.00%10,000.00%12,000.00%14,000.00%16,000.00%AugustSeptemberOctoberNovemberDecember2025
5,886.22%
15,880.51%
DGX
GILD

Key characteristics

Sharpe Ratio

DGX:

0.77

GILD:

0.43

Sortino Ratio

DGX:

1.35

GILD:

0.76

Omega Ratio

DGX:

1.15

GILD:

1.11

Calmar Ratio

DGX:

0.62

GILD:

0.35

Martin Ratio

DGX:

4.06

GILD:

0.72

Ulcer Index

DGX:

3.80%

GILD:

14.63%

Daily Std Dev

DGX:

19.98%

GILD:

24.51%

Max Drawdown

DGX:

-49.46%

GILD:

-70.82%

Current Drawdown

DGX:

-7.29%

GILD:

-5.40%

Fundamentals

Market Cap

DGX:

$16.93B

GILD:

$114.46B

EPS

DGX:

$7.42

GILD:

$0.09

PE Ratio

DGX:

20.38

GILD:

1.02K

PEG Ratio

DGX:

1.77

GILD:

0.53

Total Revenue (TTM)

DGX:

$7.25B

GILD:

$21.18B

Gross Profit (TTM)

DGX:

$2.34B

GILD:

$16.51B

EBITDA (TTM)

DGX:

$1.39B

GILD:

$1.33B

Returns By Period

In the year-to-date period, DGX achieves a 0.72% return, which is significantly higher than GILD's -0.57% return. Over the past 10 years, DGX has outperformed GILD with an annualized return of 10.38%, while GILD has yielded a comparatively lower 2.19% annualized return.


DGX

YTD

0.72%

1M

0.28%

6M

4.58%

1Y

16.46%

5Y*

9.48%

10Y*

10.38%

GILD

YTD

-0.57%

1M

0.82%

6M

28.83%

1Y

9.51%

5Y*

12.36%

10Y*

2.19%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DGX vs. GILD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DGX
The Risk-Adjusted Performance Rank of DGX is 7070
Overall Rank
The Sharpe Ratio Rank of DGX is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of DGX is 6868
Sortino Ratio Rank
The Omega Ratio Rank of DGX is 6363
Omega Ratio Rank
The Calmar Ratio Rank of DGX is 7070
Calmar Ratio Rank
The Martin Ratio Rank of DGX is 7777
Martin Ratio Rank

GILD
The Risk-Adjusted Performance Rank of GILD is 5757
Overall Rank
The Sharpe Ratio Rank of GILD is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of GILD is 5353
Sortino Ratio Rank
The Omega Ratio Rank of GILD is 5454
Omega Ratio Rank
The Calmar Ratio Rank of GILD is 6262
Calmar Ratio Rank
The Martin Ratio Rank of GILD is 5555
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DGX vs. GILD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DGX, currently valued at 0.77, compared to the broader market-2.000.002.004.000.770.43
The chart of Sortino ratio for DGX, currently valued at 1.35, compared to the broader market-4.00-2.000.002.004.001.350.76
The chart of Omega ratio for DGX, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.11
The chart of Calmar ratio for DGX, currently valued at 0.62, compared to the broader market0.002.004.006.000.620.35
The chart of Martin ratio for DGX, currently valued at 4.06, compared to the broader market-10.000.0010.0020.004.060.72
DGX
GILD

The current DGX Sharpe Ratio is 0.77, which is higher than the GILD Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of DGX and GILD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
0.77
0.43
DGX
GILD

Dividends

DGX vs. GILD - Dividend Comparison

DGX's dividend yield for the trailing twelve months is around 1.98%, less than GILD's 3.35% yield.


TTM20242023202220212020201920182017201620152014
DGX
Quest Diagnostics Incorporated
1.98%1.96%2.02%2.08%1.40%1.85%1.99%2.34%1.83%1.72%2.07%1.92%
GILD
Gilead Sciences, Inc.
3.35%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%0.00%

Drawdowns

DGX vs. GILD - Drawdown Comparison

The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum GILD drawdown of -70.82%. Use the drawdown chart below to compare losses from any high point for DGX and GILD. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-7.29%
-5.40%
DGX
GILD

Volatility

DGX vs. GILD - Volatility Comparison

Quest Diagnostics Incorporated (DGX) and Gilead Sciences, Inc. (GILD) have volatilities of 4.93% and 5.04%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%10.00%AugustSeptemberOctoberNovemberDecember2025
4.93%
5.04%
DGX
GILD

Financials

DGX vs. GILD - Financials Comparison

This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab